Quantitative Systematic Strategies LLC Lexicon Pharmaceuticals, Inc. Transaction History

Quantitative Systematic Strategies LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$3.45 - $9.09 $117,596 - $309,841	-34,086 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$1.05 - $3.67 $35,790 - $125,095	34,086 New	34,086 $117,000
Q3 2019 Nov 07, 2019	SELL	$1.2 - $6.66 $24,777 - $137,515	-20,648 Closed	0 $0
Q2 2019 Jul 25, 2019	BUY	$5.35 - $7.11 $44,415 - $59,027	8,302 Added 67.24%	20,648 $130,000
Q1 2019 Apr 15, 2019	SELL	$4.36 - $7.94 $159,358 - $290,207	-36,550 Reduced 74.75%	12,346 $69,000

Q4 2018 Feb 12, 2019	BUY	$6.15 - $10.51 $163,239 - $278,966	26,543 Added 118.74%	48,896 $325,000
Q3 2018 Nov 14, 2018	BUY	$10.32 - $13.06 $5,490 - $6,947	532 Added 2.44%	22,353 $239,000
Q2 2018 Aug 07, 2018	BUY	$7.8 - $13.69 $20,670 - $36,278	2,650 Added 13.82%	21,821 $262,000
Q1 2018 May 04, 2018	BUY	$7.86 - $11.39 $57,346 - $83,101	7,296 Added 61.44%	19,171 $164,000
Q4 2017 Feb 01, 2018	BUY	$8.77 - $12.28 $104,143 - $145,825	11,875	11,875 $117,000

122

159M

2.11M

412K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $313M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.